Compare IDEXX Laboratories, Inc. (IDXX) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs iShares 10 20 Year Treasury Bond ETF — how do they compare? IDEXX Laboratories, Inc. trades at $543.91 (market cap $43.58B), while iShares 10 20 Year Treasury Bond ETF trades at $97.48. Which is the better fit depends on your goals.
| IDXX | TLH | |
|---|---|---|
Market Cap | $43.58B | — |
Sector | Health | Fixed Income |
52-Week High | $766.68 | $105.36 |
52-Week Low | $526.44 | $97.13 |
Enterprise Value | $44.48B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories trades at $552.46, down 2.64% today, with neutral technical signals but strong fundamental performance. The company maintains robust profitability with 24.63% net margins and has beaten earnings expectations for three consecutive quarters. Recent news highlights AI integration in medical devices and upcoming Q2 2026 results on August 4, 2026. The stock shows consistent revenue growth from $3.4B in 2022 to $4.3B in 2025.
Outlook remains positive given earnings momentum and analyst consensus, though elevated valuation ratios (P/E 41.49) pose risks. Key catalysts include Q2 earnings release and continued AI adoption in veterinary diagnostics. Primary risks involve competitive pressures and market volatility affecting premium valuations.
TLH trades at $98.13, down 0.56% over 24 hours, with technical indicators signaling a bearish trend. The stock faces resistance near $99 and support at $97. Recent dividend payments of $0.41 and $0.36 in mid-2026 provide income, but key financial ratios like P/E and ROE are unavailable, limiting fundamental clarity. Broader market volatility, driven by Federal Reserve uncertainty and geopolitical tensions, adds to the cautious backdrop.
The outlook for TLH remains guarded due to weak technical momentum and lack of visible fundamental strength. Investment opportunity hinges on improved earnings visibility and stabilization above key support. Risks include macroeconomic pressures and absence of current financial metrics, warranting careful monitoring for signs of operational improvement or further deterioration.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About iShares 10 20 Year Treasury Bond ETF
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →
